2025-04-012026-03-312026-03-31false10995585Facesthetics Limited2026-06-03falseiso4217:GBPxbrli:pure109955852025-03-31109955852026-03-31109955852025-04-012026-03-31109955852024-03-31109955852025-03-31109955852024-04-012025-03-3110995585bus:SmallEntities2025-04-012026-03-3110995585bus:AuditExempt-NoAccountantsReport2025-04-012026-03-3110995585bus:FullAccounts2025-04-012026-03-3110995585bus:PrivateLimitedCompanyLtd2025-04-012026-03-3110995585core:WithinOneYear2026-03-3110995585core:AfterOneYear2026-03-3110995585core:WithinOneYear2025-03-3110995585core:AfterOneYear2025-03-3110995585core:ShareCapital2026-03-3110995585core:SharePremium2026-03-3110995585core:RevaluationReserve2026-03-3110995585core:OtherReservesSubtotal2026-03-3110995585core:RetainedEarningsAccumulatedLosses2026-03-3110995585core:ShareCapital2025-03-3110995585core:SharePremium2025-03-3110995585core:RevaluationReserve2025-03-3110995585core:OtherReservesSubtotal2025-03-3110995585core:RetainedEarningsAccumulatedLosses2025-03-3110995585core:LandBuildings2026-03-3110995585core:PlantMachinery2026-03-3110995585core:Vehicles2026-03-3110995585core:FurnitureFittings2026-03-3110995585core:OfficeEquipment2026-03-3110995585core:NetGoodwill2026-03-3110995585core:IntangibleAssetsOtherThanGoodwill2026-03-3110995585core:ListedExchangeTraded2026-03-3110995585core:UnlistedNon-exchangeTraded2026-03-3110995585core:LandBuildings2025-03-3110995585core:PlantMachinery2025-03-3110995585core:Vehicles2025-03-3110995585core:FurnitureFittings2025-03-3110995585core:OfficeEquipment2025-03-3110995585core:NetGoodwill2025-03-3110995585core:IntangibleAssetsOtherThanGoodwill2025-03-3110995585core:ListedExchangeTraded2025-03-3110995585core:UnlistedNon-exchangeTraded2025-03-3110995585core:LandBuildings2025-04-012026-03-3110995585core:PlantMachinery2025-04-012026-03-3110995585core:Vehicles2025-04-012026-03-3110995585core:FurnitureFittings2025-04-012026-03-3110995585core:OfficeEquipment2025-04-012026-03-3110995585core:NetGoodwill2025-04-012026-03-3110995585core:IntangibleAssetsOtherThanGoodwill2025-04-012026-03-3110995585core:ListedExchangeTraded2025-04-012026-03-3110995585core:UnlistedNon-exchangeTraded2025-04-012026-03-3110995585core:MoreThanFiveYears2025-04-012026-03-3110995585core:Non-currentFinancialInstruments2026-03-3110995585core:Non-currentFinancialInstruments2025-03-3110995585dpl:CostSales2025-04-012026-03-3110995585dpl:DistributionCosts2025-04-012026-03-3110995585core:LandBuildings2025-04-012026-03-3110995585core:PlantMachinery2025-04-012026-03-3110995585core:Vehicles2025-04-012026-03-3110995585core:FurnitureFittings2025-04-012026-03-3110995585core:OfficeEquipment2025-04-012026-03-3110995585dpl:AdministrativeExpenses2025-04-012026-03-3110995585core:NetGoodwill2025-04-012026-03-3110995585core:IntangibleAssetsOtherThanGoodwill2025-04-012026-03-3110995585dpl:GroupUndertakings2025-04-012026-03-3110995585dpl:ParticipatingInterests2025-04-012026-03-3110995585dpl:GroupUndertakingscore:ListedExchangeTraded2025-04-012026-03-3110995585core:ListedExchangeTraded2025-04-012026-03-3110995585dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2025-04-012026-03-3110995585core:UnlistedNon-exchangeTraded2025-04-012026-03-3110995585dpl:CostSales2024-04-012025-03-3110995585dpl:DistributionCosts2024-04-012025-03-3110995585core:LandBuildings2024-04-012025-03-3110995585core:PlantMachinery2024-04-012025-03-3110995585core:Vehicles2024-04-012025-03-3110995585core:FurnitureFittings2024-04-012025-03-3110995585core:OfficeEquipment2024-04-012025-03-3110995585dpl:AdministrativeExpenses2024-04-012025-03-3110995585core:NetGoodwill2024-04-012025-03-3110995585core:IntangibleAssetsOtherThanGoodwill2024-04-012025-03-3110995585dpl:GroupUndertakings2024-04-012025-03-3110995585dpl:ParticipatingInterests2024-04-012025-03-3110995585dpl:GroupUndertakingscore:ListedExchangeTraded2024-04-012025-03-3110995585core:ListedExchangeTraded2024-04-012025-03-3110995585dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2024-04-012025-03-3110995585core:UnlistedNon-exchangeTraded2024-04-012025-03-3110995585core:NetGoodwill2026-03-3110995585core:IntangibleAssetsOtherThanGoodwill2026-03-3110995585core:LandBuildings2026-03-3110995585core:PlantMachinery2026-03-3110995585core:Vehicles2026-03-3110995585core:FurnitureFittings2026-03-3110995585core:OfficeEquipment2026-03-3110995585core:AfterOneYear2026-03-3110995585core:WithinOneYear2026-03-3110995585core:ListedExchangeTraded2026-03-3110995585core:UnlistedNon-exchangeTraded2026-03-3110995585core:ShareCapital2026-03-3110995585core:SharePremium2026-03-3110995585core:RevaluationReserve2026-03-3110995585core:OtherReservesSubtotal2026-03-3110995585core:RetainedEarningsAccumulatedLosses2026-03-3110995585core:NetGoodwill2025-03-3110995585core:IntangibleAssetsOtherThanGoodwill2025-03-3110995585core:LandBuildings2025-03-3110995585core:PlantMachinery2025-03-3110995585core:Vehicles2025-03-3110995585core:FurnitureFittings2025-03-3110995585core:OfficeEquipment2025-03-3110995585core:AfterOneYear2025-03-3110995585core:WithinOneYear2025-03-3110995585core:ListedExchangeTraded2025-03-3110995585core:UnlistedNon-exchangeTraded2025-03-3110995585core:ShareCapital2025-03-3110995585core:SharePremium2025-03-3110995585core:RevaluationReserve2025-03-3110995585core:OtherReservesSubtotal2025-03-3110995585core:RetainedEarningsAccumulatedLosses2025-03-3110995585core:NetGoodwill2024-03-3110995585core:IntangibleAssetsOtherThanGoodwill2024-03-3110995585core:LandBuildings2024-03-3110995585core:PlantMachinery2024-03-3110995585core:Vehicles2024-03-3110995585core:FurnitureFittings2024-03-3110995585core:OfficeEquipment2024-03-3110995585core:AfterOneYear2024-03-3110995585core:WithinOneYear2024-03-3110995585core:ListedExchangeTraded2024-03-3110995585core:UnlistedNon-exchangeTraded2024-03-3110995585core:ShareCapital2024-03-3110995585core:SharePremium2024-03-3110995585core:RevaluationReserve2024-03-3110995585core:OtherReservesSubtotal2024-03-3110995585core:RetainedEarningsAccumulatedLosses2024-03-3110995585core:AfterOneYear2025-04-012026-03-3110995585core:WithinOneYear2025-04-012026-03-3110995585core:Non-currentFinancialInstrumentscore:CostValuation2025-04-012026-03-3110995585core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2025-04-012026-03-3110995585core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2025-04-012026-03-3110995585core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2025-04-012026-03-3110995585core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2025-04-012026-03-3110995585core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2025-04-012026-03-3110995585core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2025-04-012026-03-3110995585core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2025-04-012026-03-3110995585core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2025-04-012026-03-3110995585core:Non-currentFinancialInstrumentscore:CostValuation2026-03-3110995585core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2026-03-3110995585core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2026-03-3110995585core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2026-03-3110995585core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2026-03-3110995585core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2026-03-3110995585core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2026-03-3110995585core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2026-03-3110995585core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2026-03-3110995585core:Non-currentFinancialInstrumentscore:CostValuation2025-03-3110995585core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2025-03-3110995585core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2025-03-3110995585core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2025-03-3110995585core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2025-03-3110995585core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2025-03-3110995585core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2025-03-3110995585core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2025-03-3110995585core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2025-03-3110995585bus:Director12025-04-012026-03-31

Facesthetics Limited

Registered Number
10995585
(England and Wales)

Unaudited Financial Statements for the Year ended
31 March 2026

Facesthetics Limited
Company Information
for the year from 1 April 2025 to 31 March 2026

Director

Dr Helen Davison

Registered Address

Fulford Lodge 1 Heslington Lane
Fulford
York
YO10 4HW

Registered Number

10995585 (England and Wales)
Facesthetics Limited
Statement of Financial Position
31 March 2026

Notes

2026

2025

£

£

£

£

Fixed assets
Intangible assets33,000-
Tangible assets48,5235,452
11,5235,452
Current assets
Stocks67,2068,026
Debtors73,8876,764
Cash at bank and on hand46,36252,138
57,45566,928
Creditors amounts falling due within one year8(15,721)(16,054)
Net current assets (liabilities)41,73450,874
Total assets less current liabilities53,25756,326
Provisions for liabilities9(1,520)(853)
Net assets51,73755,473
Capital and reserves
Called up share capital100100
Profit and loss account51,63755,373
Shareholders' funds51,73755,473
The financial statements were approved and authorised for issue by the Director on 3 June 2026, and are signed on its behalf by:
Dr Helen Davison
Director
Registered Company No. 10995585
Facesthetics Limited
Notes to the Financial Statements
for the year ended 31 March 2026

1.Accounting policies
Statutory information
The company is a private company limited by shares and registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.
Statement of compliance
These financial statements have been prepared in compliance with FRS 102 Section 1A, The Financial Reporting Standard applicable in the UK and Republic of Ireland.
Basis of preparation
The financial statements have been prepared on the historical cost basis.
Functional and presentation currency
The financial statements are presented in sterling, which is the functional currency of the entity.
Going concern
The UK economy has recently been impacted by rising inflation, interest rates and energy costs, exacerbated by the war in Ukraine. All these matters have impacted the company's trading results to a greater or lesser extent. At the date of signing these financial statements, the directors have considered the effect of these matters on the company with the information available to it and do not believe that it will affect the ability of the company to continue to trade for the foreseeable future. On this basis, the directors have prepared these financial statements on a going concern basis.
Turnover policy
The turnover shown in the profit and loss account represents income receivable from cosmetic treatments carried out during the period. Revenue in respect of cosmetic treatment uncompleted at the year end date is recognised by reference to the state of completion.
Interest income
Interest income is recognised using the effective interest rate method.
Current taxation
The taxation expense represents the aggregate amount of current and deferred tax recognised in the reporting period. Tax is recognised in profit or loss, except to the extent that it relates to items recognised in other comprehensive income or directly in equity. In this case, tax is recognised in other comprehensive income or directly in equity, respectively. Current tax is recognised on taxable profit for the current and past periods. Current tax is measured at the amount of tax expected to pay or recover using the tax rates and laws that have been enacted, or substantively enacted, at the reporting date.
Deferred tax
Deferred tax is recognised in respect of all timing differences at the reporting date. Unrelieved tax losses and other deferred tax assets are recognised to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Deferred tax is measured using the tax rates and laws that have been enacted, or substantively enacted, by the reporting date that are expected to apply to the reversal of the timing difference.
Intangible assets
Intangible assets are stated at cost less accumulated amortisation and accumulated impairment losses. The assets are reviewed for impairment if the above factors indicate that the carrying amount may be impaired.
Tangible fixed assets and depreciation
Tangible assets are initially recorded at cost, and subsequently stated at cost less any accumulated depreciation and impairment losses. Depreciation is calculated so as to write off the cost or valuation of an asset, less its residual value, over the useful economic life of that asset as follows:

Reducing balance (%)
Plant and machinery20
Office Equipment20
Finance leases and hire purchase contracts
Assets held under finance leases and hire purchase contracts are recognised in the statement of financial position as assets and liabilities at the lower of the fair value of the assets and the present value of the minimum lease payments, which is determined at the inception of the lease term. Any initial direct costs of the lease are added to the amount recognised as an asset. Lease payments are apportioned between the finance charges and reduction of the outstanding lease liability using the effective interest method. Finance charges are allocated to each period so as to produce a constant rate of interest on the remaining balance of the liability.
Stocks and work in progress
Stocks are measured at the lower of cost and estimated selling price less costs to complete and sell. Cost includes all cost of purchase, cost of conversion and other costs incurred in bringing the stock to its present location and condition.
Trade and other debtors
Short term debtors are measured at transaction price (which is usually the invoice price), less any impairment losses for bad and doubtful debts. Loans and other financial assets are initially recognised at transaction price including any transaction costs and subsequently measured at amortised cost determined using the effective interest method, less any impairment losses for bad and doubtful debts.
Financial instruments
A financial asset or a financial liability is recognised only when the entity becomes a party to the contractual provisions of the instrument. Basic financial instruments are initially recognised at transaction price and measured at amortised cost using the effective interest method. Where investments in non-derivative financial instruments are publicly traded, or their fair value can otherwise be measured reliably, the investment is subsequently measured at fair value through profit and loss. All other investments are subsequently measured at cost less impairment. Financial assets which are measured at cost or amortised cost are reviewed for objective evidence of impairment at each balance sheet date. If there is objective evidence of impairment, an impairment loss is recognised in profit or loss immediately. All equity instruments, regardless of significance, and other financial assets that are individually significant, are assessed individually for impairment.
2.Average number of employees

20262025
Average number of employees during the year11
3.Intangible assets

Other

Total

££
Cost or valuation
Additions3,0003,000
At 31 March 263,0003,000
Net book value
At 31 March 263,0003,000
At 31 March 25--
4.Tangible fixed assets

Plant & machinery

Office Equipment

Total

£££
Cost or valuation
At 01 April 259,1338149,947
Additions5,201-5,201
At 31 March 2614,33481415,148
Depreciation and impairment
At 01 April 254,3321634,495
Charge for year2,0001302,130
At 31 March 266,3322936,625
Net book value
At 31 March 268,0025218,523
At 31 March 254,8016515,452
5.Impairment of tangible fixed assets
A review for indicators of impairment is carried out at each reporting date, with the recoverable amount being estimated where such indicators exist. Where the carrying value exceeds the recoverable amount, the asset is impaired accordingly. Prior impairments are also reviewed for possible reversal at each reporting date.
6.Stocks
Stocks are measured at the lower of cost and estimated selling price less costs to complete and sell. Cost includes all cost of purchase, cost of conversion and other costs incurred in bringing the stock to its present location and condition.

2026

2025

££
Raw materials and consumables7,2068,026
Total7,2068,026
7.Debtors: amounts due within one year

2026

2025

££
Trade debtors / trade receivables2,1506,307
Other debtors1,084457
Prepayments and accrued income653-
Total3,8876,764
8.Creditors: amounts due within one year

2026

2025

££
Trade creditors / trade payables6642,258
Taxation and social security4,1908,042
Finance lease and HP contracts3,737-
Other creditors5,4314,672
Accrued liabilities and deferred income1,6991,082
Total15,72116,054
9.Provisions for liabilities

2026

2025

££
Net deferred tax liability (asset)1,520853
Total1,520853
10.Related party transactions
During the year the directors made available a loan to the company. At the year end the balance of the loan was £5,431 (2025: £4,671)